002262 恩华药业
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资146,3221.68%143,91197,31872,54678,384
投资性房地产49,246-1.12%49,80452,03650,51652,629
固定资产1,232,7550.85%1,222,3581,237,8231,141,1561,145,313
在建工程321,073-12.26%365,938309,381293,76092,071
无形资产285,18514.50%249,078232,090190,466111,104
商誉0--0000
其他非流动资产733,4390.58%729,190451,806325,191351,249
2,768,0210.28%2,760,2792,380,4542,073,6341,830,750

流动资产
货币资金1,424,270-1.75%1,449,6061,416,3892,158,9461,532,214
应收账款1,759,47219.54%1,471,8671,490,2281,034,736820,839
存货695,228-8.13%756,784661,394628,637716,340
其他流动资产2,995,6487.58%2,784,6972,491,5411,432,2411,581,010
6,874,6186.37%6,462,9526,059,5525,254,5614,650,403

流动负债
短期借款61,000103.33%30,00015,00055,00030,000
应付票据309,787-0.66%311,846280,52560,91529,558
应付帐款312,55227.52%245,103287,828216,284226,181
其他流动负债523,9963.70%505,291482,888481,829508,204
1,207,33510.54%1,092,2401,066,241814,028793,943
流动资产净值5,667,2825.52%5,370,7134,993,3114,440,5343,856,460
资产总额减流动负债8,435,3033.74%8,130,9927,373,7656,514,1685,687,210

非流动负债
长期借款2300.00%230230230230
应付债券0--0000
其他非流动负债89,575-12.92%102,866100,019103,830103,253
89,805-12.89%103,096100,249104,060103,483

总权益
    实收股本1,015,7870.00%1,015,7871,016,1771,007,5881,007,588
    储备项目7,358,7624.51%7,041,3486,284,1455,426,5534,613,926
股东权益8,374,5493.94%8,057,1357,300,3226,434,1415,621,515
非控股权益(29,051)-0.64%(29,239)(26,806)(24,034)(37,788)